marketwatch: "new migraine drugs have promise -- and a ,500 price tag."., and bones, and it�s not clear how the drugs will affect them after long-term use..

while all of the drugs work on cgrp, they don�t all work the same way. three of them target the cgrp molecule itself. aimovig goes after cgrp's receptor in the brain..